The sale of Zila's nutraceutical business to NBTY, including
Ester-C, has completed, marking the new owner's entry into
ingredients and freeing up the old owner's attention for its core
cancer detection interests.
Zila Nutritionals is expanding availability of Ester-C, an advanced
form of vitamin C with a new agreement with distributor Gee Lawson
covering most of Europe.
A double-blind clinical trial of Zila's Ester-C has added more
support to the tolerability of the supplement; more support to the
company's tolerance claims.
Zila Nutraceuticals has developed and patented a new form of
Ester-C said to offer improved antioxidant and anti-carcinogenic
potential, which should allow it to maintain its advantage in the
vitamin C market until the end of next...
Zila Nutraceuticals are continuing their expansion into south east
Asia with a new agreement with Lohaspia to distribute its Ester-C
advanced vitamin C ingredient in Taiwan and Korea.
Zila Nutraceuticals, the US firm that makes enhanced absorption
vitamin C and E, is expanding its sales in Europe with two separate
agreements in the Scandinavian region.
A survey published in Advances in Therapy indicates that
Ester-C vitamin supplements may reduce the severity of symptoms and
shorten the duration of the common cold.